Evaxion Biotech A/S ADR (EVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVAX | AMGN | VRTX | REGN | BMY |
| Company | Evaxion Biotech A/S ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.99 | 310.88 | 402.77 | 958.00 | 44.16 |
| High | 3.99 | 312.73 | 407.59 | 962.10 | 44.62 |
| Low | 3.87 | 297.52 | 401.16 | 950.27 | 43.89 |
| Last | 4.16 | 299.38 | 404.45 | 956.42 | 43.93 |
| Change | +0.21 | -11.91 | +3.37 | -0.58 | -0.06 |
| % Change | +5.32% | -3.83% | +0.84% | -0.06% | -0.14% |
| Volume | 6,090 | 2,615,986 | 548,103 | 151,105 | 4,379,886 |
| 20-Day Average Volume | 22,087 | 2,683,377 | 1,010,727 | 508,137 | 14,057,462 |
| Previous Close | 3.95 | 311.29 | 401.08 | 957.00 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.08 | 273.81 | 398.37 | 910.65 | 47.11 |
| 20-Day Raw Stochastic | 48.34% | 63.58% | 72.74% | 90.70% | 7.93% |
| 20-Day Relative Strength | 49.61% | 63.09% | 48.86% | 58.08% | 29.28% |
| Weighted Alpha | -61.83 | +27.97 | +15.13 | +27.81 | -36.19 |
| Today's Opinion | 56% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 80% Sell | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.93% since 04/29/24 | +8.56% since 04/29/24 | +1.73% since 04/29/24 | +6.90% since 04/29/24 | -1.44% since 04/29/24 |
| Low | 3.85 on 05/03/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 | 43.33 on 05/02/24 |
| High | 4.20 on 04/30/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | +7.05% since 04/05/24 | +11.15% since 04/05/24 | -0.89% since 04/05/24 | +1.20% since 04/05/24 | -14.27% since 04/05/24 |
| Low | 3.52 on 04/11/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.41 on 04/19/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | -12.22% since 02/06/24 | -5.07% since 02/06/24 | -3.14% since 02/06/24 | +1.73% since 02/06/24 | -10.69% since 02/06/24 |
| Low | 2.82 on 03/07/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.74 on 02/12/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -64.41% since 11/06/23 | +9.98% since 11/06/23 | +4.49% since 11/06/23 | +14.61% since 11/06/23 | -16.66% since 11/06/23 |
| Low | 2.82 on 03/07/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 13.61 on 01/24/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,600 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 5,215 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 70,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -22,130,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 70,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -4,520,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | -0.22 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 03/27/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/29/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |